Home
About
Overview
Sharing Data
ORCID
Help
History (11)
A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes.
Truncation of NHEJ1 in a patient with polymicrogyria.
Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes.
The T cell death knell: immune-mediated tumor death in renal cell carcinoma.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The T cell death knell: immune-mediated tumor death in renal cell carcinoma.
The T cell death knell: immune-mediated tumor death in renal cell carcinoma. Clin Cancer Res. 2001 Oct; 7(10):3276-81.
View in:
PubMed
subject areas
Adaptor Proteins, Signal Transducing
Antibodies, Monoclonal
Apoptosis
Carcinoma, Renal Cell
Carrier Proteins
Caspase 8
Caspase 9
Caspases
Drug Resistance, Neoplasm
Enzyme Activation
Fas Ligand Protein
fas Receptor
Fas-Associated Death Domain Protein
Granzymes
Humans
Jurkat Cells
Membrane Glycoproteins
Necrosis
Perforin
Pore Forming Cytotoxic Proteins
Serine Endopeptidases
T-Lymphocytes, Cytotoxic
Tumor Cells, Cultured
authors with profiles
Christopher Froelich